
Marjorie G. Zauderer, MD
Thoracic Oncologist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Co-Director, MSK Mesothelioma Program
I am a board-certified medical oncologist who specializes in caring for people with thoracic cancers and I am Co-Director of MSK’s Mesothelioma Program. I provide personalized care to my patients throughout their treatment. Care plans are based not only on the type of cancer and its genomics but also on the priorities of each and every patient and family.
I work closely with my colleagues from other disciplines such as thoracic surgery, radiation oncology, pulmonology, pathology, radiology, and interventional radiology to determine the optimal plan and whether there is an appropriate clinical trial.
Read more
I also lead a research team working to develop new therapies for mesothelioma and lung cancer. I am particularly interested in inherited predispositions to lung cancer and mesothelioma. I work on developing treatments for specific molecular changes, such as MTAP, BAP1 and NF2 loss, as well as novel immunotherapies and biomarkers that may predict response to these new treatments. My work has been supportive by the National Cancer Institute and the Department of Defense as well as several philanthropic sources.
I have previously served on the Scientific Advisory Board for the Mesothelioma Applied Research Foundation and am now Chair of the Board of Directors. I am a member of the Mesothelioma Committee of the International Association for the Study of Lung Cancer. I review grants for the National Institutes of Health, National Cancer Institute, and Department of Defense and serve as an Editorial Board Member for Clinical Lung Cancer. I have completed MSK’s Physician Executive Development Program as well as the American Society of Clinical Oncology Leadership Development Program. At MSK, I also serve as the Thoracic Disease Management Team lead for the MSK Cancer Alliance which helps ensure that our outstanding care and innovative clinical trials are accessible to people closer to their homes.
A thoracic oncologist is a cancer doctor with special training in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Lung Cancer
- Mesothelioma
- Multiple Primary Lung Cancers
Education
- MD, Columbia University
Residencies
- Internal Medicine - New York Presbyterian/Columbia University Medical Center
Fellowships
- Hematology/Medical Oncology - Memorial Sloan Kettering Cancer Center
- Medicine - Weill Cornell Medical College
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

New Patients
Current Patients
Contact and Location
Dr. Zauderer sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Clinical Trials
- Clinical Trials Investigated by Dr. Zauderer
- A Phase 1 Study of VT3989 in People With Mesothelioma
- Clinical Trials Co-Investigated by Dr. Zauderer
- A Phase 1 Study of TNG908 in People with Sarcoma and Mesothelioma
- A Phase I Study of Pembrolizumab Immunotherapy and Radiation Therapy in People with Inoperable Pleural Mesothelioma
- A Study of Nivolumab Immunotherapy and Chemotherapy followed by Surgery for Pleural Mesothelioma

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Zauderer’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Marjorie G. Zauderer discloses the following relationships and financial interests:
-
Curis
Professional Services and Activities -
Medscape
Professional Services and Activities
-
Mesothelioma Applied Research Foundation
Fiduciary Role / Position
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].